The osteoporosis drug Reclast reduces the risk of additional hip fractures in older people, a Novartis-funded study found. In observing 2,127 men and women who had broken their hips within three months prior to the study and took calcium and vitamin D supplements, researchers found that intravenous administration of Reclast once a year significantly lowered the chances of patients suffering repeat fractures, which are associated with an increased risk of death in older adults.

Full Story:
USA Today

Related Summaries